🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Cancer Screening intervention

Found 0 matching trials

Use of PET Imaging to Distinguish Malignant From Benign IPMN

Intraductal papillary mucinous neoplasm (IPMN) is a cystic pancreatic lesio...

Status

Terminated

Location

Columbia University Medical Center

Start Date

2009-09

Trial ID

NCT01104116

Treatments Being Tested

[18F]-FDG PET/CT imaging

Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)

N/A

The primary objective of this study is to gather stool samples from subject...

Status

Completed

Location

Digestive Health Specialists of the Southeast

Start Date

2014-09

Trial ID

NCT02503696

Treatments Being Tested

Stool Collection Kit

Default Option Nudging Intervention to Improve the Adherence Rates of Cancer Screening

The goal of this clinical trial is to learn if a behavioral "nudge" strateg...

Status

Completed

Location

Harbin Medical University

Start Date

2025-04-27

Trial ID

NCT07682220

Treatments Being Tested

Default Options

Reengineering Cervical Cancer Screening for the 21st Century: Joint Action for a Novel Up-to-date and Sustainable Screening Program

Cervical cancer screening (CCS) is important to prevent and control cervica...

Status

Enrolling By Invitation

Location

Unidade Local de Saúde Gaia e Espinho

Start Date

2025-04-10

Trial ID

NCT06915610

Treatments Being Tested

Invitation of all participants to CCS according to the standard of care (active comparator)Invitation of all participants to CCS through self-sampling Invitation of all participants to CCS, asking them to choose between self-sampling and the standard of care Invitation of all participants to CCS according to the standard of care, followed by invitation of those non-adherent to CCS through self-sampling Invitation of all participants to CCS through self-sampling, followed by invitation of those non-adherent to CCS according to the standard of care Invitation of all participants to CCS, asking them to choose between self-sampling and the standard of care; this mode of invitation is repeated when participants do not adhere to the first invitation

Integrating Artificial Intelligence Into Lung Cancer Screening.

Lung cancer (LC) screening using low-dose chest CT (LDCT) has already prove...

Status

Recruiting

Location

CHU de Nice - Hôpital de Pasteur

Start Date

2024-04-08

Trial ID

NCT05704920

Treatments Being Tested

IA Not IA

Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities

The purpose of this study is to determine if a new device, called the Endoc...

Status

Unknown

Location

County Durham and Darlington NHS Foundation Trust

Start Date

2014-11

Trial ID

NCT02552017

Treatments Being Tested

Endocuff Vision

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

PHASE1

The purpose of this trial is to estimate the recommended dose (RD) of \[177...

Status

Active Not Recruiting

Location

UCLA Jonsson Comp Cancer Center

Start Date

2023-11-13

Trial ID

NCT05870579

Treatments Being Tested

[68Ga]Ga-NeoB [177Lu]Lu-NeoB Ribociclib Fulvestrant Goserelin

Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto I

Prostate Cancer (PCa) screening is still a controversial topic in the urolo...

Status

Unknown

Location

Sapienza University of Rome

Start Date

2020-09-21

Trial ID

NCT04803188

Treatments Being Tested

Magnetic Resonance

Cabozantinib and Nivolumab for Carcinoid Tumors

PHASE2

This research study, is studying the combination of cabozantinib and nivolu...

Status

Completed

Location

Boston Medical Center

Start Date

2019-12-26

Trial ID

NCT04197310

Treatments Being Tested

Nivolumab Cabozantinib

Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning

Lung cancer is the number one cancer killer in Kentucky and has a very high...

Status

Completed

Location

Hazard ARH Regional Medical Center

Start Date

2004-11

Trial ID

NCT00596310

Treatments Being Tested

Previous Next